IL6 and COVID-19: Fourthly, the analysis was performed with baseline biomarkers and with a limited set of serial measurements and number of IL-6 determination, which, had they been available for all patients, could have been extremely relevant to better understand the relationship between noncritically ill COVID-19 patients, long COVID-19, and survival.